• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用无创伤生物发光成像来评估小鼠分枝杆菌的传播、杀菌药物的治疗作用和保护免疫。

Use of non-invasive bioluminescent imaging to assess mycobacterial dissemination in mice, treatment with bactericidal drugs and protective immunity.

机构信息

Department of Microbiology, Karolinska Institute, Box 280, 17177 Stockholm, Sweden.

出版信息

Microbes Infect. 2009 Dec;11(14-15):1114-21. doi: 10.1016/j.micinf.2009.08.005. Epub 2009 Aug 12.

DOI:10.1016/j.micinf.2009.08.005
PMID:19682599
Abstract

Monitoring the spread of mycobacterium in vivo using biophotonic imaging provides a fast, reliable and sensitive method to evaluate the distribution of the infection. Moreover, this technique allows for a significant reduction in the number of animals required in comparison to conventional anatomopathological studies. Here, we describe for the first time and validate the use of a luciferase-tagged recombinant Mycobacterium bovis BCG for non-invasive bioluminescent imaging of 1) bacterial dissemination in tissues, 2) the efficacy of treatment with anti-mycobacterial drugs and 3) the role of adaptive immune responses in controlling mycobacterial infection in vivo.

摘要

利用生物发光成像技术监测体内分枝杆菌的传播提供了一种快速、可靠和敏感的方法来评估感染的分布。此外,与传统的解剖病理学研究相比,该技术可以显著减少所需动物的数量。在这里,我们首次描述并验证了使用荧光素酶标记的重组牛分枝杆菌卡介苗进行非侵入性生物发光成像的用途,用于 1)细菌在组织中的传播,2)抗分枝杆菌药物治疗的效果,以及 3)适应性免疫反应在控制体内分枝杆菌感染中的作用。

相似文献

1
Use of non-invasive bioluminescent imaging to assess mycobacterial dissemination in mice, treatment with bactericidal drugs and protective immunity.利用无创伤生物发光成像来评估小鼠分枝杆菌的传播、杀菌药物的治疗作用和保护免疫。
Microbes Infect. 2009 Dec;11(14-15):1114-21. doi: 10.1016/j.micinf.2009.08.005. Epub 2009 Aug 12.
2
Luciferase in vivo expression technology: use of recombinant mycobacterial reporter strains to evaluate antimycobacterial activity in mice.荧光素酶体内表达技术:利用重组分枝杆菌报告菌株评估小鼠体内抗分枝杆菌活性。
Antimicrob Agents Chemother. 1996 Feb;40(2):400-7. doi: 10.1128/AAC.40.2.400.
3
Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice.用重组肝素结合血凝素粘附素进行粘膜免疫可抑制牛分枝杆菌卡介苗(BCG)在感染小鼠体内的肺外播散。
Vaccine. 2008 Feb 13;26(7):924-32. doi: 10.1016/j.vaccine.2007.12.005. Epub 2007 Dec 26.
4
A New Screen for Tuberculosis Drug Candidates Utilizing a Luciferase-Expressing Recombinant Mycobacterium bovis Bacillus Calmette-Guéren.一种利用表达荧光素酶的重组牛分枝杆菌卡介苗筛选抗结核药物候选物的新方法。
PLoS One. 2015 Nov 16;10(11):e0141658. doi: 10.1371/journal.pone.0141658. eCollection 2015.
5
Primary isoniazid resistance in Mycobacterium bovis disease: a prospect of concern.牛分枝杆菌疾病中的原发性异烟肼耐药性:一个值得关注的问题。
Am J Respir Crit Care Med. 2012 Jul 1;186(1):110-1. doi: 10.1164/ajrccm.186.1.110.
6
[Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].[结核分枝杆菌在感染结核分枝杆菌的H37RV小鼠中使用三种一线药物(利福平、异烟肼、吡嗪酰胺)治疗后持续存在的实验证据]
Probl Tuberk Bolezn Legk. 2004(3):32-7.
7
Aerosol infection of mice with recombinant BCG secreting murine IFN-gamma partially reconstitutes local protective immunity.用分泌小鼠干扰素-γ的重组卡介苗对小鼠进行气溶胶感染,可部分重建局部保护性免疫。
Microb Pathog. 2000 Sep;29(3):175-85. doi: 10.1006/mpat.2000.0382.
8
Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy.添加硫利达嗪增强结核药物的体外活性,但并未在体内治疗效果改善中得到体现。
Tuberculosis (Edinb). 2014 Dec;94(6):701-7.
9
[Frontier of mycobacterium research--host vs. mycobacterium].[分枝杆菌研究前沿——宿主与分枝杆菌]
Kekkaku. 2005 Sep;80(9):613-29.
10
Postoperative spondylodiscitis caused by Mycobacterium bovis BCG: a case study.牛分枝杆菌卡介苗引起的术后椎间盘炎:病例研究。
Spine J. 2012 Dec;12(12):e1-5. doi: 10.1016/j.spinee.2012.10.024. Epub 2012 Nov 20.

引用本文的文献

1
Improved Conventional and New Approaches in the Diagnosis of Tuberculosis.结核病诊断中传统方法与新方法的改进
Front Microbiol. 2022 May 31;13:924410. doi: 10.3389/fmicb.2022.924410. eCollection 2022.
2
Evaluation of Nucleoside Analogs as Antimicrobials Targeting Unique Enzymes in .核苷类似物作为针对……中独特酶的抗菌剂的评估
Pathogens. 2020 Aug 20;9(9):678. doi: 10.3390/pathogens9090678.
3
Rapid Tuberculosis Diagnosis Using Reporter Enzyme Fluorescence.利用报告酶荧光快速诊断结核病。
J Clin Microbiol. 2019 Nov 22;57(12). doi: 10.1128/JCM.01462-19. Print 2019 Dec.
4
Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence.利用报告酶荧光成像技术对小鼠体内的结核分枝杆菌进行成像。
J Vis Exp. 2018 Feb 26(132):56801. doi: 10.3791/56801.
5
A Fluorescent Probe for Detecting and Identifying Genes Critical for Cell Entry.一种用于检测和鉴定细胞进入关键基因的荧光探针。
Front Microbiol. 2016 Dec 20;7:2021. doi: 10.3389/fmicb.2016.02021. eCollection 2016.
6
Intravital excitation increases detection sensitivity for pulmonary tuberculosis by whole-body imaging with β-lactamase reporter enzyme fluorescence.活体激发通过β-内酰胺酶报告酶荧光全身成像提高肺结核检测灵敏度。
J Biophotonics. 2017 Jun;10(6-7):821-829. doi: 10.1002/jbio.201600132. Epub 2016 Oct 18.
7
Bioluminescence for assessing drug potency against nonreplicating Mycobacterium tuberculosis.用于评估抗非复制型结核分枝杆菌药物效力的生物发光法。
Antimicrob Agents Chemother. 2015 Jul;59(7):4012-9. doi: 10.1128/AAC.00528-15. Epub 2015 Apr 20.
8
Real-time bioluminescence imaging of mixed mycobacterial infections.混合分枝杆菌感染的实时生物发光成像
PLoS One. 2014 Sep 29;9(9):e108341. doi: 10.1371/journal.pone.0108341. eCollection 2014.
9
Simple and rapid method to determine antimycobacterial potency of compounds by using autoluminescent Mycobacterium tuberculosis.利用自发光结核分枝杆菌测定化合物抗分枝杆菌效力的简单快速方法。
Antimicrob Agents Chemother. 2014 Oct;58(10):5801-8. doi: 10.1128/AAC.03205-14. Epub 2014 Jul 21.
10
Role for Gr-1+ cells in the control of high-dose Mycobacterium bovis recombinant BCG.Gr-1+细胞在控制高剂量牛分枝杆菌重组卡介苗中的作用。
Clin Vaccine Immunol. 2014 Aug;21(8):1120-7. doi: 10.1128/CVI.00363-14. Epub 2014 Jun 11.